These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 26093138)

  • 1. [Plasma NGAL and ADPKD progression].
    Virzì GM; Gastaldon F; Corradi V; de Cal M; Cruz DN; Clementi M; Ronco C
    G Ital Nefrol; 2015; 32(3):. PubMed ID: 26093138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Genotype-phenotype correlation in ADPKD: a possible role for NGAL?].
    Virzì GM; Gastaldon F; Corradi V; de Cal M; Cruz DN; Clementi M; Ronco C
    G Ital Nefrol; 2013; 30(4):. PubMed ID: 24941494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The utility of serum neutrophil gelatinase-associated lipocalin level on predicting autosomal dominant polycystic kidney disease progression.
    Uysal C; Koyuncu S; Ipekten F; Karakukcu C; Kocyigit I
    Ther Apher Dial; 2024 Oct; 28(5):760-768. PubMed ID: 38773764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of NGAL in early stage chronic kidney disease.
    Basturk T; Sari O; Koc Y; Eren N; Isleem M; Kara E; Sevinc M; Sakaci T; Ahbap E; Hasbal NB; Bayrakdar Caglayan F; Unsal A
    Minerva Urol Nefrol; 2017 Jun; 69(3):307-312. PubMed ID: 27768023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of Urinary Neutrophil Gelatinase-Associated Lipocalin for Predicting the Severity of Renal Functions in Patients With Autosomal-Dominant Polycystic Kidney Disease.
    Vareesangthip K; Vareesangthip K; Limwongse C; Reesukumal K
    Transplant Proc; 2017 Jun; 49(5):950-954. PubMed ID: 28583565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma neutrophil gelatinase-associated lipocalin and kidney function decline and kidney disease-related clinical events in older women.
    Lim WH; Lewis JR; Wong G; Teo R; Lim EM; Byrnes E; Prince RL
    Am J Nephrol; 2015; 41(2):156-64. PubMed ID: 25824561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma neutrophil gelatinase-associated lipocalin (NGAL) is an indicator of interstitial damage and a predictor of kidney function worsening of chronic kidney disease in the early stage: a pilot study.
    Moriya H; Mochida Y; Ishioka K; Oka M; Maesato K; Hidaka S; Ohtake T; Kobayashi S
    Clin Exp Nephrol; 2017 Dec; 21(6):1053-1059. PubMed ID: 28397074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of urinary biomarkers with disease severity in patients with autosomal dominant polycystic kidney disease: a cross-sectional analysis.
    Meijer E; Boertien WE; Nauta FL; Bakker SJ; van Oeveren W; Rook M; van der Jagt EJ; van Goor H; Peters DJ; Navis G; de Jong PE; Gansevoort RT
    Am J Kidney Dis; 2010 Nov; 56(5):883-95. PubMed ID: 20888104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implications of the changes in serum neutrophil gelatinase-associated lipocalin and cystatin C in patients with chronic kidney disease.
    Shen SJ; Hu ZX; Li QH; Wang SM; Song CJ; Wu DD; He JL; Guan JC; Shan JP
    Nephrology (Carlton); 2014 Mar; 19(3):129-35. PubMed ID: 24397346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Copeptin levels and kidney function in ADPKD: case-control study.
    Corradi V; Martino F; Gastaldon F; Scalzotto E; Caprara C; Fortunato A; Pinaffo G; Marchetti C; Fabbi F; Giavarina D; Ferrari F; Rosner MH; Ronco C
    Clin Nephrol; 2016 Sep; 86(9):147-53. PubMed ID: 27487355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neutrophil gelatinase-associated lipocalin: a novel marker of contrast nephropathy risk.
    McCullough PA; Williams FJ; Stivers DN; Cannon L; Dixon S; Alexander P; Runyan D; David S
    Am J Nephrol; 2012; 35(6):509-14. PubMed ID: 22627273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neutrophil gelatinase-associated lipocalin in patients with autosomal-dominant polycystic kidney disease.
    Bolignano D; Coppolino G; Campo S; Aloisi C; Nicocia G; Frisina N; Buemi M
    Am J Nephrol; 2007; 27(4):373-8. PubMed ID: 17570904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutrophil gelatinase-associated lipocalin is a new and sensitive marker of kidney function in chronic kidney disease patients and renal allograft recipients.
    Malyszko J; Malyszko JS; Bachorzewska-Gajewska H; Poniatowski B; Dobrzycki S; Mysliwiec M
    Transplant Proc; 2009; 41(1):158-61. PubMed ID: 19249502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of atorvastatin on NGAL and cystatin C in chronic kidney disease: a post hoc analysis of the LORD trial.
    Fassett RG; Robertson IK; Ball MJ; Geraghty DP; Cardinal JW; Coombes JS
    Nephrol Dial Transplant; 2012 Jan; 27(1):182-9. PubMed ID: 21543653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subclinical and clinical contrast-induced acute kidney injury: data from a novel blood marker for determining the risk of developing contrast-induced nephropathy (ENCINO), a prospective study.
    Akrawinthawong K; Ricci J; Cannon L; Dixon S; Kupfer K; Stivers D; Alexander P; David S; McCullough PA
    Ren Fail; 2015 Mar; 37(2):187-91. PubMed ID: 25519207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma neutrophil gelatinase-associated lipocalin as a predictive biomarker for the detection of acute kidney injury in adult poisoning.
    Ahn JY; Lee MJ; Seo JS; Choi D; Park JB
    Clin Toxicol (Phila); 2016; 54(2):127-33. PubMed ID: 26683351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma neutrophil gelatinase-associated lipocalin measured in consecutive patients after congenital heart surgery using point-of-care technology.
    Koch AM; Dittrich S; Cesnjevar R; Rüffer A; Breuer C; Glöckler M
    Interact Cardiovasc Thorac Surg; 2011 Aug; 13(2):133-6. PubMed ID: 21606051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical application of neutrophil gelatinase-associated lipocalin in the revised chronic kidney disease classification.
    Xiang D; Zhang H; Bai J; Ma J; Li M; Gao J; Wang C
    Int J Clin Exp Pathol; 2014; 7(10):7172-81. PubMed ID: 25400814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma NGAL predicts early acute kidney injury no earlier than s-creatinine or cystatin C in severely burned patients.
    Rakkolainen I; Vuola J
    Burns; 2016 Mar; 42(2):322-8. PubMed ID: 26724852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma Neutrophil Gelatinase-Associated Lipocalin as a Predictor of Cardiovascular Events in Patients with Chronic Kidney Disease.
    Hasegawa M; Ishii J; Kitagawa F; Takahashi H; Sugiyama K; Tada M; Kanayama K; Takahashi K; Hayashi H; Koide S; Nakai S; Ozaki Y; Yuzawa Y
    Biomed Res Int; 2016; 2016():8761475. PubMed ID: 27051671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.